Navigation Links
Elekta's Leksell Gamma Knife Perfexion is Ranked 2011's Best in KLAS for Radiation Therapy
Date:6/24/2011

ATLANTA, June 24, 2011 /PRNewswire/ -- Elekta's Leksell Gamma Knife® Perfexion™ earned the number one ranking in the KLAS research firm's recently released 2011 Top 20 Best in KLAS Awards: Medical Equipment & Infrastructure* report. Perfexion received Best in KLAS in the radiation therapy category.

In the report, Perfexion scored 92.9 out of 100 and 95 percent of customers indicated they would buy again. On a 1 to 9 scale, Perfexion received an 8.6 from respondents for satisfaction with product uptime, the highest score among all vendors rated in the market segment.

"Leksell Gamma Knife has been the gold standard for radiosurgery for many years," says Jay Hoey, Executive Vice President, Elekta North America. "Our latest generation solution, Perfexion, was designed and developed based on the insight of expert Leksell Gamma Knife users. The Best in KLAS designation recognizes not only the sophistication of this radiosurgery platform, but also the contributions of our clinical partners in making it a reality."

Elekta posted record-breaking sales of Leksell Gamma Knife systems in 2010, confirming the growing demand for the system as a safe, effective modality to treat brain metastases and other cranial disorders.

Gamma Knife® surgery is a gentler alternative to traditional brain surgery for illnesses such as metastatic disease – cancer that has traveled to the brain from elsewhere in the body. The system precisely delivers up to thousands of low-intensity radiation beams to one or more targets in a single session. Leksell Gamma Knife Perfexion provides even greater speed and ease of use than previous versions, especially for treating multiple metastases.

Supported by three decades of clinical practice in both neurosurgery and radiation oncology departments, more than 50,000 patients each year are treated with Gamma Knife surgery.

KLAS gathers opinions of thousands of healthcare professionals

The KLAS awards are based on data from customer surveys of hospital and clinic executives, administrators, physicians, nurses and other directors and managers interacting with healthcare equipment and infrastructure solutions.

According to KLAS, Best in KLAS designations go to solutions that have excelled in their respective market segments, that show the vendor's leadership in working with customers to resolve issues and match expectations to reality, and that have the broadest operational and clinical impact to healthcare organizations.

"Best in KLAS recognition – which indicates leadership in working with customers to resolve issues and match needs to delivered solutions – is awarded to healthcare vendors who have consistently excelled in their market segment(s)," says Adam Gale, president of KLAS. "We are pleased that the healthcare industry recognizes the value of the 'Best in KLAS' award. The awards in this report help put the aggregate perceptions and opinions of healthcare executives and clinicians into perspective – especially as their peers consider major investment decisions."

The 2011 Top 20 Best in KLAS Awards: Medical Equipment & Infrastructure report is available online. To purchase the full report, visit www.KLASresearch.com/BestinKLAS.

*2011 Top 20 Best in KLAS Awards: Medical Equipment & Infrastructure," June, 2011. © 2011 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elekta Emphasizes Advantages of Leksell Gamma Knife Perfexion Over Competing Systems at 2011 AANS Meeting
2. Treatment with Elektas Leksell Gamma Knife Perfexion Introduced to Cancer Patients in Australia
3. Islanders and Tourists with Brain Cancer to Benefit from Hawaiian Centers Installment of Elektas Leksell Gamma Knife Perfexion
4. Physicians See New Benefits, Treatment Opportunities for Brain Cancer with Elektas Leksell Gamma Knife Perfexion
5. Karolinska University Hospital Acquires Leksell Gamma Knife Perfexion to Expand Radiosurgery Versatility, Efficiency in Brain Cancer Therapy
6. University of Pittsburgh Medical Center (UPMC) Treats 10,000th Patient with Leksell Gamma Knife Radiosurgery System
7. Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion
8. Elekta Announces Clinical Start-Up of New Leksell Gamma Knife(R) Perfexion(TM) at UPMC
9. Devicor™ Medical Products, Inc. Agrees to Acquire Neoprobes Gamma Detection Devices
10. First-ever Gamma Knife in Paris Offers New Treatment Options for Patients With Cancer and Other Brain Disorders
11. MEDX Installs Two Next Generation T-Quest™ Compact Gamma Cameras
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016  Pennsylvania Physician General Dr. ... Alcohol Programs Gary Tennis released safe ... as benzodiazepines, developed with the help of a ... that are frequently prescribed for anxiety or insomnia," ... with opioid pain medications, benzodiazepines pose a significant ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, LLC ... obtained proof-of-mechanism for neflamapimod (previously code named VX-745), ... 2a clinical trials that demonstrated significant Alzheimer,s disease ... (12-week treatment) and Study 303 (6-week treatment) are ... in Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has ... to their offering. ... The global chromatography market to grow at ... Chromatography Market 2016-2020, has been prepared based on an in-depth market analysis ... its growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims to ... that are both engaging and easy to use. Coming off the heels of ... revealed today its plans to roll out new AI-powered self-service enhancements to help ...
(Date:12/8/2016)... ... ... STATEN ISLAND, N.Y., Nov. 24, 2016 — Richmond ... of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) services from three ... , Among the recognitions, the American College of Surgeons' (ACS) named the hospital's ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
(Date:12/8/2016)... ... 08, 2016 , ... Dickinson Insurance and Financial Services, an ... Rock, has initiated a charity drive to provide support and funding to the ... Hunger, Arkansas ranks first in senior hunger statewide, third in child hunger, and ...
(Date:12/8/2016)... Goodyear, AZ (PRWEB) , ... December 08, 2016 ... ... planning firm with offices that serve communities in and around the greater Phoenix ... to the Homeless Youth Connection. , The mission of the Homeless Youth Connection ...
Breaking Medicine News(10 mins):